Accurate, Affordable and Early Cancer Diagnosis
Epi One's groundbreaking cancer diagnostic technology seeks to change the lives of millions of people every single year by detecting cancer early so the resulting treatment has the best chance of leading to a cure.
After receiving a cancer diagnosis, the next words you want to hear are:
“But we caught it early”.
Many cancers are treatable when diagnosed early. But traditional screening methods, like X-rays, CAT scans and even genomic sequencing tests, can take several days, weeks, or even months for results. They can be expensive and they can be inaccurate. Far too many people don’t receive a cancer diagnosis until it’s too late.
As a result, cancer is the second leading cause of death globally.
At Epi One, we believe we can change this.
We believe we can save millions of lives every year by diagnosing cancer early, accurately and affordably. Our transformational cancer screening process is as simple as a blood test, and is faster, cheaper and more accurate than anything else available.
Our scientific team is pioneering disruptive cancer biomarker identification technologies that enable early cancer diagnosis, post-detection monitoring, and prognosis assessment. And this is all achieved via a simple cancer diagnosis assay that produces highly accurate test results in as little as seven hours!
The end result? Significantly higher survival rates for those suffering from cancer.
The Epi One Solution
ONE BLOOD DRAW WITH A PCR TEST
FOR ACCURATE CANCER DIAGNOSIS
Highly
Accurate
Simple
PCR test
<10 Biomarkers
per test
<1/3 of sequencing cost
7 Hour
Turnaround